Novartis AG
METHODS FOR PREVENTING AND TREATING HEART DISEASE

Last updated:

Abstract:

The disclosure relates to novel uses and methods for preventing and/or treating heart disease, which employ a therapeutically effective amount of an ActRII receptor antagonist, e.g., an ActRII receptor binding molecule, e.g., an ActRII receptor antibody, such as the bimagrumab antibody.

Status:
Application
Type:

Utility

Filling date:

16 Mar 2021

Issue date:

7 Oct 2021